Quiz Page November 2008: A Family History of Kidney Failure and Hearing Loss

References 

1. Fye KH. Diagnosis of Muckle Wells syndrome—30 Years later. J Rheumatol. 2007;34:2505–2506
2. Messier G, Meyrier A, Rainfray M, Coste T, Callard P. Overt or occult renal amyloidosis in the Muckle-Wells syndrome. Kidney Int. 1988;34:566;(abstr)
3. Agostini L, Martinon F, Burns K, et al. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity. 2004;20:319–325
   • MEDLINE
   • CrossRef
4. Gillmore JD, Lovat LB, Persey R, et al. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet. 2001;358:24–29
   • Abstract
   • Full Text
   • Full-Text PDF (575 KB)
   • CrossRef
5. Aganna E, Martinon F, Hawkins PN, et al. Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum. 2002;46:2445–2452
   • MEDLINE
   • CrossRef
6. Maksimovic L, Stirnemann E, Caux F, et al. New CIAS1 mutation and anakinra efficacy in overlapping of Muckle Wells and familial cold autoinflammatory syndromes. Rheumatology. 2008;47:309–310
7. Hawkins PN, Lachmann HJ, McDermott MF. Interleukin-1-receptor antagonist in Muckle-Wells syndrome. N Engl J Med. 2003;348:2583–2584
   • CrossRef
8. Mirault T, Launay D, Cuisset L, et al. Recovery from deafness in a patient with Muckle-Wells syndrome treated with anakinra. Arthritis Rheum. 2006;54:1697–1700
   • MEDLINE
   • CrossRef